✦ LIBER ✦

Relationship of antibodies to infliximab to duration of response and infusion reactions for Crohn's disease patients receiving episodic infliximab retreatment in ACCENT I

✍ Scribed by Wagner, Carrie; Hanauer, Stephen B.; Bala, Mohan; Patel, Kamlesh; Travers, Suzanne; Olson, Allan; Rutgeerns, Paul

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of antibodies to infliximab on in

✍ Wagner, Carrie; Ford, Joyce; Marsters, Paul; Travers, Suzanne; Bao, Weihang; Dev 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Incidence and importance of antibody res

✍ Hanauer, Stephen B; Wagner, Carrie L; Bala, Mohan; Mayer, Lloyd; Travers, Suzann 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 217 KB

Successful induction of tolerance to inf

✍ C. DUBURQUE; J. LELONG; R. IACOB; M. SEDDIK; P. DESREUMAUX; C. FOURNIER; B. WALL 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 604 KB

P.06.20 ROLE OF TROUGH LEVELS AND ANTIBO

✍ Marzo, M.; Armuzzi, A.; Felice, C.; Pugliese, D.; Andrisani, G.; Tolusso, B.; Gr 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 851 KB

Smoking, age, duration of disease, gende

✍ Fefferman, David S.; Lodhavia, Parag J.; Reinert, Steven; Hani, Abdallah; Falchu 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 176 KB

C-reactive protein, an indicator for mai

✍ W. Reinisch; Y. Wang; B. J. Oddens; R. Link 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB